Hideki Yasui

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Therapeutic advances in respiratory disease

Respirology (Carlton, Vic.)

Respiratory research

American journal of respiratory and critical care medicine

Hamamatsu University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Hamamatsu University School of Medicine Apr 1o 2017

Japan

PHD :: Second Division of Internal Medicine

Publications

Yasutaka Mochizuka, Noriyuki Enomoto, Akahori Daisuke, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Mineo Katsumata, Dai Hashimoto, Shiro Imokawa, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Kazuhiro Tabata, Takeshi Johkoh, Takafumi Suda
"Bull's-Eye" Sign and Its Longitudinal Change on HRCT in Pulmonary Sarcoidosis. American journal of respiratory and critical care medicine (2023)
Takahito Suzuki, Masato Karayama, Yoichiro Aoshima, Kazutaka Mori, Nobuko Yoshizawa, Shintaro Ichikawa, Shinpei Kato, Koshi Yokomura, Masato Kono, Dai Hashimoto, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Satoshi Goshima, Naoki Inui, Takafumi Suda
Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias. Respirology (Carlton, Vic.) (2023)
Yasutaka Mochizuka, Yuzo Suzuki, Masato Kono, Hirotsugu Hasegawa, Dai Hashimoto, Koshi Yokomura, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.) (2023)
Yurina Murakami, Hideki Yasui, Jun Sato, Tomohiro Uto, Naoki Inui, Takafumi Suda, Shiro Imokawa
Predictors of poor clinical outcomes including in-hospital death and low ability to perform activities of daily living at discharge in hospitalized patients with chronic obstructive pulmonary disease exacerbation. Therapeutic advances in respiratory disease 17 (2023)
Daisuke Akahori, Naoki Inui, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Takafumi Suda
Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice. International journal of molecular sciences 23 (16) (2022)
Yuya Aono, Noriyuki Enomoto, Masato Kono, Hidenori Nakamura, Koshi Yokomura, Shiro Imokawa, Mikio Toyoshima, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis. Therapeutic advances in respiratory disease 14 (2021)
Takafumi Koyauchi, Hideki Yasui, Noriyuki Enomoto, Hirotsugu Hasegawa, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Koshi Yokomura, Takafumi Suda
Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease. Therapeutic advances in respiratory disease 14 (2021)
Akira Yamagata, Machiko Arita, Hiromasa Tachibana, Fumiaki Tokioka, Chikatoshi Sugimoto, Hiromitsu Sumikawa, Tomonori Tanaka, Hideki Yasui, Tomoyuki Fujisawa, Yutaro Nakamura, Takafumi Suda, Tadashi Ishida
Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respiratory research 22 (1) (2021)
Noriyuki Enomoto, Hyogo Naoi, Yuya Aono, Mineo Katsumata, Yasuoki Horiike, Hideki Yasui, Masato Karayama, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Takafumi Suda
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis. Therapeutic advances in respiratory disease 14 (2021)
Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Takafumi Suda
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial. Respirology (Carlton, Vic.) 26 (4) (2020)
Norimichi Akiyama, Hironao Hozumi, Takuya Isayama, Jun Okada, Katsunori Sugiura, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Takafumi Suda
Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.) 25 (7) (2019)
Mitsuru Niwa, Tomoyuki Fujisawa, Kazutaka Mori, Katsumasa Yamanaka, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Tetsuro Suzuki, Masato Maekawa, Takafumi Suda
IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium. Journal of immunology (Baltimore, Md. : 1950) 201 (8) (2018)

Hideki Yasui.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hideki Yasui